Enoximone
Chemical compound / From Wikipedia, the free encyclopedia
Enoximone (INN, trade name Perfan) is an imidazole phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure and is selective for phosphodiesterase 3.[1]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Perfan |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 50% (oral) |
Protein binding | 85% |
Metabolism | Liver (oxidation) |
Elimination half-life | 4 to 10 hours |
Excretion | Renal (60 to 70%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H12N2O2S |
Molar mass | 248.30 g·mol−1 |
3D model (JSmol) | |
Melting point | 255 to 258 °C (491 to 496 °F) (decomposes) |
| |
| |
(verify) |
Close